Vedanta Ltd
BSE:500295
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vedanta Ltd
BSE:500295
|
IN |
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
US |
|
N
|
Nuvama Wealth Management Ltd
NSE:NUVAMA
|
IN |
Wall St Price Targets
VEDL Price Targets Summary
Vedanta Ltd
According to Wall Street analysts, the average 1-year price target for VEDL is 795.69 INR with a low forecast of 267.57 INR and a high forecast of 1 049.67 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VEDL's stock price target?
Price Target
795.69
INR
According to Wall Street analysts, the average 1-year price target for VEDL is 795.69 INR with a low forecast of 267.57 INR and a high forecast of 1 049.67 INR.
What is the Revenue forecast for Vedanta Ltd?
Projected CAGR
-11%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 4 years is -11%.
What is the Gross Profit forecast for Vedanta Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 23%. The projected CAGR for the next 4 years is -5%.
What is the Operating Income forecast for Vedanta Ltd?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 4 years is -4%.
What is the Pre-Tax Income forecast for Vedanta Ltd?
Projected CAGR
30%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is 30%.
What is the Net Income forecast for Vedanta Ltd?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 4 years is -7%.
